These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 1386634)

  • 21. Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
    Cartel JL; Millan J; Guelpa-Lauras CC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):461-5. PubMed ID: 6686970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].
    Goulart IM; Arbex GL; Carneiro MH; Rodrigues MS; Gadia R
    Rev Soc Bras Med Trop; 2002; 35(5):453-60. PubMed ID: 12621663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis and multi-drug therapy in leprosy with special reference to prothionamide.
    Kar HK; Balakrishnan S; Vasantha Kumar G; Sirumban P; Roy RG
    Indian J Lepr; 1985; 57(1):78-89. PubMed ID: 3839828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
    Chopra NK; Agarwal JS; Pandya PG
    Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of leprosy.
    Biswas SK;
    J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
    Singh RP; Tiwari VD; Chattopadhyay SP
    Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis.
    Yang J; Kong J; Li B; Ji Z; Liu A; Chen J; Liu M; Fan Y; Peng L; Song J; Wu X; Gao L; Ma W; Dong Y; Luo S; Bao F
    J Infect; 2023 Apr; 86(4):338-351. PubMed ID: 36796681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S; Catorze MG; Vieira MR
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
    Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
    Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
    Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol.
    Krismawati H; Ferdiana A; Irwanto A; Budiawan T; Imaniar C; Wahyuni T; Singh P; Mieras L; Pongtiku A
    BMJ Open; 2022 May; 12(5):e057173. PubMed ID: 35545382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.